Cellectis SA (CLLS)
1.53
+0.02
(+1.32%)
USD |
NASDAQ |
Apr 25, 16:00
1.55
+0.02
(+1.31%)
After-Hours: 20:00
Cellectis Shareholders Equity (Quarterly): 131.03M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 27.39M |
| Genfit SA | 104.36M |
| Edap TMS SA | 42.56M |
| Akari Therapeutics PLC | 22.23M |
| Biodexa Pharmaceuticals PLC | 10.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 383.54M |
| Total Liabilities (Quarterly) | 252.51M |
| Debt to Equity Ratio | 0.3727 |
| Current Ratio | 1.726 |
| Net Debt Paydown Yield | -2.60% |